Rocket Lab USA, Inc. Profile Avatar - Palmy Investing

Rocket Lab USA, Inc.

Rocket Lab USA, Inc., a space company, provides launch services and space systems solutions for the space and defense industries. The company provides launch services, spacecraft engineering and design services, spacecraft components, spacecraft manufact…
Aerospace & Defense
US, Long Beach [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 33% Weak
Leverage & Liquidity 33% Weak
Per Share Metrics 100% Best
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 12.58 -59.89 -68.51
Graham Fair Price -13.53 1.41 1.63
PEG 68.81 1.16 -0.69
Price/Book -14.04 4.17 4.86
Price/Cash Flow -79.52 -91.85 -51.17
Prices/Earnings 15.30 -11.29 -13.33
Price/Sales -51.99 21.55 44.89
Price/FCF -79.52 -91.85 -51.17
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -12.98 0.22 0.26
Operating Margin 41.57 -0.46 -0.79
ROA 30.20 -0.04 -0.05
ROE -0.09 -0.09 -1.48
ROIC -0.07 -0.05 34.08
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 1.70 0.09 1788.94
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -0.23 0.10 -57.50
EPS QOQ -0.19 0.10 -49.82
FCF QOQ -0.14 0.59 324.92
Revenue QOQ -0.11 0.55 381.96
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 218.14 125.02 -42.69
Days Sales Outstanding (DSO) 72.20 57.65 -20.15
Inventory Turnover 0.41 0.72 74.49
Debt/Capitalization 0.16 0.46 187.96
Quick Ratio 1.31 2.37 81.07
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 1.14 0.98 -14.17
Cash 0.50 1.01 99.97
Capex -0.02 -0.04 -83.01
Free Cash Flow -0.11 -0.04 58.90
Revenue 0.12 0.19 53.68
Naive Interpretation member
05 - Per Share Metrics · Best
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 2.13 3.12 46.26
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -0.36 -3.15 -777.67
Naive Interpretation Member
06 - Financial Health · Bad
End of RKLB's Analysis
CIK: 1819994 CUSIP: 773122106 ISIN: US7731221062 LEI: - UEI: -
Secondary Listings
RKLB has no secondary listings inside our databases.